Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and Metformin
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 219 participants.
Also called NCT01990469
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 219 participants
- Sponsor
- Registry
-
NCT01990469
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT01990469. Randomized; quadruple masking; primary purpose treatment. Start 2014-01 (registry gives no type); primary completion 2015-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and Metformin
- Condition
- T2DM
- Intervention (Drug)
- Gemigliptin
- Intervention (Drug)
- Gemigliptin placebo
- Lead sponsor
- LG Life Sciences
Record details
- Record id
cardio:ct-nct01990469- Content hash
6cb8338d650471f2a4e7f040fa86b21cae189019f971e7fc7c873f1bb0a9dc82